P01031 (CO5_HUMAN) Homo sapiens (Human)

Complement C5 UniProtKBInterProSTRINGInteractive Modelling

1676 aa; Sequence (Fasta)

Available Structures

30 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
cryoEM structure of 2C9-sMAC Heteromer
P02748; P07357; P07358; P07360; P10643; P13671;
19-1676
NAG;NAG;NAG;BMA;CA;NAG;FUC;
Assess
cryoEM structure of 3C9-sMAC Heteromer
P02748; P07357; P07358; P07360; P10643; P13671;
19-1676
NAG;NAG;BMA;CA;NAG;FUC;
Assess
Crystal structure of complement C5 in complex with chemically synthesized K92 knob domain. Heteromer
20-1676
NAG;EDO;
Assess
Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Dermacentor andersoni RaC… Heteromer
A0A146B485; Q5YD59;
20-1676
NAG;EDO;CYS;DIO;
Assess
Crystal structure of human complement C5 in complex with the K92 bovine knob domain peptide. Heteromer
20-1676
NAG;EDO;CYS;TRS;
Assess
Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Rhipicephalus microplus R… Heteromer
A0A158RFT4; Q5YD59;
20-1676
NAG;CYS;
Assess
Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Rhipicephalus appendicula… Heteromer
A0A141SFN4; Q5YD59;
20-1676
NAG;CYS;
Assess
Structure of complement C5 in complex with eculizumab Heteromer
20-1676
NAG;
Assess
Crystal Structure of C5b-6 Heteromer
P13671;
20-1676
NAG;FUC;NA;CA;MAN;
Assess
Structure of Complement C5 in Complex with CVF Heteromer
Q91132;
20-1676
NAG;
Assess
Structure of Complement C5 in Complex with CVF and SSL7 Heteromer
D3JIB2; Q91132;
20-1676
NAG;NAG;
Assess
Structure of human complement C5 complexed with tick inhibitors OmCI, RaCI1 and CirpT1 Heteromer
A0A141SFN4; L7MB58; Q5YD59;
20-1676
NAG;
Assess
Crystal structure of C5b6 Heteromer
P13671;
22-1676
NAG;CA;FUC;BMA;
Assess
Structure of complement C5 in complex with SSL7 Heteromer
22-1676
NAG;CD;NAG;
Assess
Crystal structure of human complement C5 in complex with the K8 bovine knob domain peptide. Heteromer
20-1513
NAG;EOH;MHA;MPD;CYS;TAM;
Assess
Structure of Complement C5 in Complex with small molecule inhibitor and CVF Heteromer
Q91132;
20-1513
H1H;MG;
Assess
Structure of complement C5 in complex with the C-terminal beta-grasp domain of SSL7 Heteromer
A0A0H3K6Z8;
22-1514
NAG;CD;NAG;
Assess
OPEN CONFORMATION OF THE MEMBRANE ATTACK COMPLEX Heteromer
P02748; P07357; P07358; P07360; P10643; P13671;
22-1369
NAG; 20×NAG; 37×NAG;
Assess
Closed conformation of the Membrane Attack Complex Heteromer
P02748; P07357; P07358; P07360; P10643; P13671;
23-1369
19×NAG; 38×NAG;
Assess
Structure of tick complement inhibitor CirpT1 complexed with macroglobubulin domain 4 of human comp… Heteromer
L7MB58;
348-458
GOL;
Assess
Crystal structure of complement C5 in complex with SKY59 Heteromer
20-121
Assess
Complex structure of human C5a and its binding repebody Heteromer
678-748
1PE;SO4;
Assess
Crystal structure of the human c5a in complex with MEDI7814 a neutralising antibody Heteromer
678-741
SO4;
Assess
Human Complement Component 5monomer20-1676
NAG;NAG;CD;
Assess
NMR Structure of C345C (NTR) domain of C5 of complementmonomer1530-1676
Assess
NMR SOLUTION STRUCTURE OF C5A AT PH 5.2, 303K, 20 STRUCTURESmonomer679-751
Assess
SOLUTION STRUCTURE OF A SEMI-SYNTHETIC C5A RECEPTOR ANTAGONIST AT PH 5.2, 303K, NMR, 20 STRUCTURESmonomer679-747
Assess
Crystal structure of the human C5aR antagonist C5a-A8monomer678-745
Assess
Crystal structure of human desarg-C5Amonomer679-743
Assess
Crystal structure of human desarg-C5Amonomer679-740
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5i5k.2.Amonomer0.7420-1676
100.00
Assess